The term 'attrition' is traditionally applied to R&D, suggesting an unpredictable loss of agents in the pipeline. The huge question has become, "Can we predict the commercial success or failure of a drug before launch?"
Tina Kohnstam of Caudex Medical explains the importance of best practise standards.
The post-mortem on the global financial crisis will rumble on for some time to come. But, for those working in PR, now is the time to consider the wider implications on corporate trust and reputation and, in particular, how the pharmaceutical industry can learn from it.
Optimizing information and collaboration will be the new key to winning or losing in Pharma. By CDM